Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

CNS Pharmaceuticals, Inc.

NASDAQ: CNSP · Life Sciences · 2 alerts · CIK 1729427

Share price
$3.48Close, Nov 16
Market cap
$5.14M
Shares outstanding
1.48MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CNS Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:31 AM ET 10-Q
Financial Results

CNS Pharmaceuticals Q3 2026 Results: Net Loss of $2.5M, Loss Narrows

CNS Pharmaceuticals reported a net loss of $10.0 million for the nine months ended September 30, 2026, while significantly strengthening its cash position to $17.2 million following a $22.5 million private placement in May 2026. The company is currently pivoting its corporate strategy toward acquiring new therapeutic assets and exploring out-licensing opportunities for its legacy glioblastoma programs.

Key figure
Net loss $2.5M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.